to 64.5%) had histologically confirmed gestational trophoblastic disease. Assuming the approximation that there was no additional GTD in patients with negative scans who did not have histological tissue for analysis, the sensitivity of ultrasound was 70.00% (95% CI 61.99% to 77.20%) with a specificity of 99.88 % (95% CI 99.85% to 99.91%). The likelihood ratio for GTD after a positive ultrasound was 602.24, with a post-test probability of 0.548. Considering molar pregnancies alone, 61/69 (88.4%, 95% CI 78.5 to 94.3%) of complete moles were suspected on ultrasound preoperatively, compared with 40/74 (54.1%, 95% CI 42.8 to 64.9%) of partial moles. Conclusions: Our study supports the data published from other units showing that USS has a high sensitivity for the diagnosis of complete molar pregnancy. The diagnostic accuracy of partial moles is lower, but with a better than reported in the past.
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A randomised controlled trial comparing misoprostol to expectant care in early pregnancy failure A. Fernlund, L. Jokubkiene, P. Sladkevicius, L. Valentin
Skåne University Hospital, Malmo, Sweden
Objectives: To compare vaginal misoprostol with expectant management of early non-viable pregnancies with regard to complete evacuation of the uterine cavity within 10 days. Methods: Parallel randomised controlled, open label, trial. Randomisation was carried out by an off-site research service centre. Patients with early pregnancy failure (anembryonic or early fetal demise, Crown-rump length 7-33mm) and vaginal bleeding were recruited from the emergency ward of the department of obstetrics and gynecology, Skane University Hospital, Malmö, Sweden and randomly allocated to either expectant care or 800μg of misoprostol vaginally. Patients were evaluated clinically and by ultrasound until complete evacuation of the uterus. Follow-up visits were planned at 10, 17, 24 and 31 days. Dilatation and evacuation was performed if miscarriage was not complete <31 days, or earlier on patient's request, or if there was excessive bleeding. Main outcome measure: Number of patients with complete miscarriage <10 days. Clinical Trials NCT01033903. Results: 94 patients were randomised to misoprostol and 95 to expectant care. After exclusion of 3 patients and withdrawal of consent by 2 patients 184 patients (n=94, n=90) were left to intention to treat analysis. After 10 days complete miscarriage was achieved in 66 % of the patients treated with misoprostol and in 43% of the patients with expectant management. 2 patients from each group underwent emergency D&E because of bleeding <10 days (2.1% vs. 2.2%). After 31 days of observation the rate of complete miscarriage was 86% in the misoprostol group and 61% in the expectant group. The number of D&E's on patient's request was higher in the expectantly managed group (17% vs. 3%) as was the number of patients making out of protocol visits (56% vs. 29%).
Conclusions:
Vaginal misoprostol is more effective than expectant management of early pregnancy failure with vaginal bleeding with regard to complete evacuation of the uterus. Objectives: To compare systemic and local ultrasound-guided methotrexate (MTX) therapy in uterine ectopic pregnancies regarding the β-hCG clearance. Methods: Retrospective data of forty-six women with uterine ectopic pregnancies (Caesarean scar, cervical, interstitial pregnancy) was evaluated. Patients were scanned and received either surgical treatment, MTX or expectant management. MTX was applied systemically intramuscularly or locally via ultrasound-guided injection. Primary endpoint was the β-hCG clearance duration in days. In order to investigate, whether the management (systemic MTX or local MTX) has a significant impact on the β-hCG clearance duration, a Wilcoxon Test at significance level = 0,05 was conducted. In order to investigate the effect of the management (systemic MTX or local MTX) on adverse effects (bleeding, pain, necessary interventional surgery), Fisher's exact tests were conducted. Results: Forty-six patients were diagnosed with uterine ectopic pregnancy (24 Caesarean scar, 17 interstitial, 5 cervical pregnancies). Of these, two were treated with expectant management, 39 with MTX (15 systemic; 24 local) and five were treated surgically.
There was a significant difference in β-hCG clearance duration when comparing local and systemic MTX treatment (mean 66,82 days; 35,25 days respectively; p=0,004).
There was no statistically significant difference between local versus systemic MTX regarding the occurrence of bleeding (p=0,376), pain (p=0,146) or interventional surgery (p=0,631). However, we could observe a trend towards higher occurrence of bleeding and pain in the local MTX treatment group, and higher occurrence of subsequent surgery in the systemic MTX group. Conclusions: Patients who received local MTX showed a significantly longer β-hCG clearance duration compared to patients who received systemic MTX treatment (mean difference 26,5 days). There was no statistically significant difference of adverse effects (bleeding, pain, subsequent surgery) between both groups.
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Rates of spontaneous pregnancy loss and ovulation-implantation interval within a prospective pre-conception cohort Objectives: To understand the reproductive health of a population, it is important to account for all conceptions and spontaneous pregnancy loss. Reported rates with spontaneous conceptions are conflicting. We conducted a prospective pre-conception study of women planning a pregnancy, to examine per-cycle conception and miscarriage, including early pregnancy loss (EPL) rates. Methods: Healthy women who were planning to conceive naturally were recruited into a pre-conception study. With an ovulation and pregnancy testing monitor, subjects commenced ovulation testing from cycle day 6 till LH surge was detected. Pregnancy testing commenced 7 days post-ovulation till a positive pregnancy result, or next menses. Monitor digital data was downloaded, providing semi-quantitative levels of LH and HCG. The interval between ovulation and a first rise in HCG baseline taken to represent implantation (O-I), and trend of rise in hCG, were related to pregnancy outcome (viable or miscarriage). Results: Of 387 women recruited, 293 pregnancies were conceived, with per-cycle conception rate of 34.2% and interval to conception of 3.1 months. 87 pregnancies ended in 1st trimester miscarriages. 41% of miscarriages were 'biochemical' losses which would otherwise be clinically unrecognised. There were significant differences in O-I interval mean distance to median (p <0.001), and in hCG signal form as early as 1 day of rise in baseline (p <0.0001), between pregnancies that miscarried, and viable pregnancies. Conclusions: Spontaneous pregnancy per-cycle conception rate is 34.2% with pregnancy loss rate of 30%, higher than that previously reported in the literature, as EPL were also accounted for. A vast number of pregnancies are lost prior to the window of ultrasound-diagnostic miscarriage criteria. Both short and long O-I interval, and different b-hCG rise from very early stages is associated with miscarriage. Objectives: Ectopic pregnancy (EP) remains the leading early pregnancy-related cause of maternal mortality. Therefore, determining which PUL will have a final outcome of EP remains clinically important. A vaginal bacterial composition abundant in Lactobacillus species can be associated with healthy pregnancy outcomes and an atypical/ anaerobic bacterial composition can be associated with poor pregnancy outcomes (e.g. preterm birth). We aimed to compare the vaginal bacterial composition of PUL with different final outcomes. Methods: Vaginal swabs were collected at 4-7 weeks gestation. The final outcome was confirmed at 12 weeks gestation as either: failed PUL (FPUL, n=27), ectopic pregnancy (EP, n=19), persistent PUL (PPUL, n=9), viable or non-viable intrauterine pregnancy (VIUP, n=22; NVIUP, n=15). VIUP were used as controls. Bacteria composition was examined using MiSeq (Illumina) sequencing of bacterial 16S rRNA genes (hypervariable regions V1-V2). Sequence data was processed using the Mothur pipeline and analysed in the Statistical Analysis of Metagenomic Profiles (STAMP) programme. * This presentation is eligible for the Young Investigator award (to be presented in the closing plenary).
Results: Hierarchical clustering of genera sequence data permitted samples to be classified as 
